Evidence map›Paper›PMID 33343566›Full record

ArticleFrontiers in immunology2020

Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to

Ekaterina A Kurbatova, Nelli K Akhmatova, Anton E Zaytsev, Elina A Akhmatova, Nadezhda B Egorova, Natalya E Yastrebova, Elena V Sukhova, Dmitriy V Yashunsky, Yury E Tsvetkov, Nikolay E Nifantiev

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ekaterina A KurbatovaLaboratory of Therapeutic Vaccines, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Nelli K AkhmatovaLaboratory of Therapeutic Vaccines, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Anton E ZaytsevLaboratory of Therapeutic Vaccines, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Elina A AkhmatovaLaboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Moscow, Russia.
Nadezhda B EgorovaLaboratory of Therapeutic Vaccines, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Natalya E YastrebovaLaboratory of Therapeutic Vaccines, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
Elena V SukhovaLaboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Moscow, Russia.
Dmitriy V YashunskyLaboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Moscow, Russia.
Yury E TsvetkovLaboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Moscow, Russia.
Nikolay E NifantievLaboratory of Glycoconjugate Chemistry, N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Moscow, Russia.
N.D. Zelinsky Institute of Organic Chemistry · RUResearch Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of studies have demonstrated the limited efficacy of

Indexed as

Immunogenicity, VaccineAnimalsAntibodies, BacterialAntibody SpecificityBacterial CapsulesBiotinylationCells, CulturedCytokinesImmunizationMaleMice, Inbred BALB COligosaccharidesPhagocytosisPneumococcal VaccinesSerum Albumin, BovineSpleen13-valent pneumococcal vaccineAntibodies, BacterialCytokinesOligosaccharidesPneumococcal VaccinesSerum Albumin, Bovinetype 3 capsular polysaccharide, Streptococcus pneumoniaeantibodyantigen-binding capacitybiotinylated oligosaccharideconjugated oligosaccharideopsonophagocytosisStreptococcus pneumoniae type 3synthetic oligosaccharidevaccine

Identifiers

PMID33343566
PMCPMC7746847
OpenAlexW3107496020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.